Ares Genetics GmbH - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - World's Most Promising AI Startups & AI Ecosystem of 10,000+ AI Startups
Get Started
Microbial infections and antibiotic resistance can affect anybody, amounting to more than 15 Mio annual cases globally.
Ares Genetics GmbH is a wholly-owned subsidiary of Curetis GmbH, a developer of next-generation molecular diagnostic solutions for infectious diseases. Ares Genetics was established in March 2017 and is located at the Vienna Biocenter, Austria. The Company builds on GEAR Genetic Antibiotic Resistance and Susceptibility Database: the most comprehensive collection of pathogen genomes and antibiotic resistance profiles, which was originally developed and compiled by the Ares Genetics management team at Siemens and acquired by the Curetis Group in late 2016. With a strong core team of bioinformatics experts and life science project managers and supported by Curetis’ IVD R&D team, the company leverages its proprietary technology platform within the Curetis Group as well as in collaborative projects with partners in industry and academia.
Total Funding: €1.3M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2017
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started